Bempikibart Shows Sustained Hair Regrowth in Alopecia Areata

Phase 2a trial data presented at AAD 2025 show bempikibart leads to sustained hair regrowth in severe alopecia areata, demonstrating for the first time an IL-7Rα antagonist approach.